St. Jude researching HIV treatment for people 16 and up
Researchers at St. Jude are partnering with dozens of medical partners globally to answer a question — how do certain HIV treatments work with 16- and 17-year-olds versus adults?
There are 11 article(s) tagged HIV:
Researchers at St. Jude are partnering with dozens of medical partners globally to answer a question — how do certain HIV treatments work with 16- and 17-year-olds versus adults?
When you hear about the country’s “social safety net,” this is it: Hope House. Multiplied by thousands of small, committed organizations in cities across America. Federal funding cuts have Hope House’s leaders worried about Memphis.
“If middle school students are having unprotected sex and contracting sexually transmitted infections, do we really think they are going to log onto a website and order a test?”
Chris Sinnock, a social worker at St. Jude Children’s Research Hospital, cites bias against condoms and dating apps as two of the elements contributing to the spread of HIV.
Opinion: Politicians must become knowledgeable about the medical and scientific advancements regarding the transmission and treatment of HIV, especially when they are advocating for the use of criminal laws.
“By implementing a scientifically informed HIV prevention strategy and using tools that are known to be effective to prevent HIV, we can End the Epidemic among our young people.”
Scott Morris: “What if more of us could truly believe God loves us in the peace-giving way of my patient all those years ago? How would we approach the complexity of an ongoing pandemic and other dangers life gives us?”
People living with HIV are being arrested and prosecuted for HIV non-disclosure when HIV transmission did not occur or was extremely unlikely to occur.
Friends for Life opened The Haven, its larger HIV/AIDS outreach and support center, near the University of Memphis Sunday, Feb. 7, on National Black HIV/AIDS Awareness Day.
We can prevent HIV, or we can prosecute it, but we cannot do both.
Three years after her diagnosis, LáDeia Joyce is in a pharmaceutical ad campaign and on the public speaking circuit.
About 11 results